The step comes amid questions about preliminary results from trials of the jab, after the company and the university acknowledged that the most encouraging part of their findings stemmed from a dosing error.
It’s the second vaccine candidate to reach the formal assessment stage in
The British government has ordered 100 million doses of the Oxford-AstraZeneca vaccine, and plans to start distributing it in December if it gains approval.
The regulator said it could not give a time frame for possible approval of the vaccines
MHRA Chief Executive
Oxford and
The drugmakers informed the
Some scientists have expressed concerns about gaps in the data and the way the results were reported. Only 2,741 people received the half dose, making it hard to know if the effectiveness seen in the group is real or a statistical quirk. A total of 8,895 people received two full doses.
“Trust is at a premium when it comes to vaccines and we must not do anything that might in any way undermine that trust,” she said.
Full results are due to be published in medical journal The
Unlike the
The British government and its scientific advisers have expressed confidence that multiple vaccines will win approval, but say all decisions are up to the regulator.
“They will make an assessment with lots of data that is not currently public domain on efficacy and on safety,” said England’s Chief Medical Officer,
“I think it’s always a mistake to make too many judgements early before we have the full information and particularly before the regulator, the independent regulator, has had their chance to look at the data and make an assessment.”
Follow AP’s pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source